UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Topiramate in migraine prophylaxis: Results from a placebo-controlled trial with propranolol as an active control

Journal of neurology, 2004-08, Vol.251 (8), p.943-950

2004

Volltextzugriff (PDF)

Ergotamine in the acute treatment of migraine : A review and European consensus

Brain (London, England : 1878), 2000, Vol.123 (1), p.9-18

2000

Volltextzugriff (PDF)

Guidelines for Controlled Trials of Drugs in Migraine: Second Edition

Cephalalgia, 2000-11, Vol.20 (9), p.765-786

2000

Volltextzugriff (PDF)

Sumatriptan Nasal Spray in the Acute Treatment of Migraine: A Review of Clinical Studies

Cephalalgia, 1999-11, Vol.19 (9), p.769-778

Dahlöf, C

1999

Volltextzugriff (PDF)

Prevalence of perceived symptoms of dry mouth in an adult Swedish population - relation to age, sex and pharmacotherapy

Community dentistry and oral epidemiology, 1997-06, Vol.25 (3), p.211-216

1997

Volltextzugriff (PDF)

Clinical efficacy and tolerability of sumatriptan tablet and suppository in the acute treatment of migraine: a review of data from clinical trials

Cephalalgia, 2001-01, Vol.21 (Supplement 1), p.9-12

Dahlof, C

2001

Volltextzugriff (PDF)

A Six-Item Short-Form Survey for Measuring Headache Impact: The HIT-6

Quality of life research, 2003-12, Vol.12 (8), p.963-974

2003

Volltextzugriff (PDF)

Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators

Cephalalgia, 2012-01, Vol.32 (1), p.6-38

2012

Volltextzugriff (PDF)

Evaluation and Registration of Adverse Events in Clinical Drug Trials in Migraine

Cephalalgia, 2008-07, Vol.28 (7), p.683-688

2008

Volltextzugriff (PDF)

Attitudes and Burden of disease among Self-Considered Migraineurs — a Nation-wide Population-based Survey in Sweden

Cephalalgia, 2004-06, Vol.24 (6), p.455-465

2004

Volltextzugriff (PDF)

Eletriptan for the Treatment of Migraine in Patients with Previous Poor Response or Tolerance to Oral Sumatriptan

Cephalalgia, 2003-07, Vol.23 (6), p.463-471

2003

Volltextzugriff (PDF)

Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache

Cephalalgia, 1998-09, Vol.18 (7), p.487-489

1998

Volltextzugriff (PDF)

One-Year Prevalence of Migraine in Sweden: A Population-Based Study in Adults

Cephalalgia, 2001-07, Vol.21 (6), p.664-671

2001

Volltextzugriff (PDF)

Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study

European journal of neurology, 1998-11, Vol.5 (6), p.535-543

1998

Volltextzugriff (PDF)

Efficacy and Safety of Tonabersat, a Gap-Junction Modulator, in the Acute Treatment of Migraine: A Double-Blind, Parallel-group, Randomized Study

Cephalalgia, 2009-11, Vol.29 (2_suppl), p.7-16

2009

Volltextzugriff (PDF)

Safety and tolerability of the novel 5-HT1B/1D agonist rizatriptan in migraineurs

Headache, 1999, Vol.39, p.S16-S18

DAHLÖF, C

1999

Volltextzugriff (PDF)

Subcutaneous Sumatriptan Provides Symptomatic Relief at any Pain Intensity or Time During the Migraine Attack

Cephalalgia, 2006-02, Vol.26 (2), p.113-121

2006

Volltextzugriff (PDF)

Diclofenac-K (50 and 100 mg) and Placebo in the Acute Treatment of Migraine

Cephalalgia, 1993-04, Vol.13 (2), p.117-123

1993

Volltextzugriff (PDF)

The Natural Course of Migraine Attacks. A Prospective Analysis of Untreated Attacks Compared with Attacks Treated with a Triptan

Cephalalgia, 2006-06, Vol.26 (6), p.712-721

2006

Volltextzugriff (PDF)

The SF-36 and the assessment of HRQoL

Cephalalgia, 1998-11, Vol.18 (9), p.592-592

Dahlof, C

1998

Volltextzugriff (PDF)

Almotriptan and zolmitriptan in the acute treatment of migraine

Acta neurologica Scandinavica, 2007-01, Vol.115 (1), p.34-40

2007

Volltextzugriff (PDF)

Indirect Cost of Migraine

Cephalalgia, 1999-01, Vol.19 (1), p.1-1

Dahlöf, C

1999

Volltextzugriff (PDF)

Infrequent or Non-Response to Oral Sumatriptan does not Predict Response to Other Triptans—Review of Four Trials

Cephalalgia, 2006-02, Vol.26 (2), p.98-106

Dahlöf, CGH

2006

Volltextzugriff (PDF)

Integrating the triptans into clinical practice

Current opinion in neurology, 2002-06, Vol.15 (3), p.317-322

Dahlöf, Carl

2002

Volltextzugriff (PDF)

Migraine Patients Experience Poorer Subjective Well-Being/Quality of Life Even Between Attacks

Cephalalgia, 1995-02, Vol.15 (1), p.31-36

1995

Volltextzugriff (PDF)

1 – 25 von 304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(244)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Topiramate in migraine prophylaxis: Results from a placebo-controlled trial with propranolol as an active control

Ergotamine in the acute treatment of migraine : A review and European consensus

Guidelines for Controlled Trials of Drugs in Migraine: Second Edition

Sumatriptan Nasal Spray in the Acute Treatment of Migraine: A Review of Clinical Studies

Prevalence of perceived symptoms of dry mouth in an adult Swedish population - relation to age, sex and pharmacotherapy

Clinical efficacy and tolerability of sumatriptan tablet and suppository in the acute treatment of migraine: a review of data from clinical trials

A Six-Item Short-Form Survey for Measuring Headache Impact: The HIT-6

Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators

Evaluation and Registration of Adverse Events in Clinical Drug Trials in Migraine

Attitudes and Burden of disease among Self-Considered Migraineurs — a Nation-wide Population-based Survey in Sweden

Eletriptan for the Treatment of Migraine in Patients with Previous Poor Response or Tolerance to Oral Sumatriptan

Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache

One-Year Prevalence of Migraine in Sweden: A Population-Based Study in Adults

Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study

Efficacy and Safety of Tonabersat, a Gap-Junction Modulator, in the Acute Treatment of Migraine: A Double-Blind, Parallel-group, Randomized Study

Safety and tolerability of the novel 5-HT1B/1D agonist rizatriptan in migraineurs

Subcutaneous Sumatriptan Provides Symptomatic Relief at any Pain Intensity or Time During the Migraine Attack

Diclofenac-K (50 and 100 mg) and Placebo in the Acute Treatment of Migraine

The Natural Course of Migraine Attacks. A Prospective Analysis of Untreated Attacks Compared with Attacks Treated with a Triptan

The SF-36 and the assessment of HRQoL

Almotriptan and zolmitriptan in the acute treatment of migraine

Indirect Cost of Migraine

Infrequent or Non-Response to Oral Sumatriptan does not Predict Response to Other Triptans—Review of Four Trials

Integrating the triptans into clinical practice

Migraine Patients Experience Poorer Subjective Well-Being/Quality of Life Even Between Attacks

Suchergebnisse filtern